Bristol-Myers Squibb’s impact on class actions

Bristol-Myers Squibb imposed new limitations on specific jurisdiction in mass actions

Robert Fisher

From Issue: 2020 June

When that which is supposed to heal, does more harm than good

An overview of the doctrinal framework of warning defects as applied to pharmaceutical-injury cases

Natali Shabani

From Issue: 2020 June

The best and worst employment case law developments of 2019

A brief overview of the most important case law developments that shaped the year in employment law (with a bit of color commentary)

Andrew H. Friedman

From Issue: 2020 May

COVID-19 business-interruption claims

Getting around the “virus” exclusion may require a lot of careful reading as language differs between policies

Ricardo Echeverria
Michael J. Bidart

From Issue: 2020 June

Sexual-harassment litigation in the post-#MeToo era

Understanding the recent changes in sexual-harassment law and seizing the opportunities created by them

Ramit Mizrahi

From Issue: 2020 May

Public speaking and the art of persuasion

Would you rather fight a mountain lion than speak to a large group of people (or a jury)?

Dustin Collier
Joshua Socks

From Issue: 2020 May